Related Experiment Video
Updated: Jul 19, 2026

Measuring the Stiffness of Ex Vivo Mouse Aortas Using Atomic Force Microscopy
Published on: October 19, 2016
Arterial stiffness and coronary ischemic disease
Bronwyn A Kingwell1, Anna A Ahimastos
1Baker Heart Research Institute, Melbourne , Australia.
Insights
Large artery stiffening contributes to coronary artery disease and heart attacks. Treatments for heart disease can reduce artery stiffness, but specific artery-stiffening drugs
Area of Science:
- Cardiovascular Science
- Medical Research
Background:
- Large artery stiffening is linked to atherosclerosis and coronary outcomes.
- Artery stiffening unfavorably impacts coronary hemodynamics, potentially causing myocardial ischemia.
- Central pulse pressure elevation is a key mechanism linking stiff arteries to heart ischemia.
Purpose of the Study:
- To explore the causal relationship between large artery stiffening and coronary outcomes.
- To investigate the role of artery stiffening in myocardial ischemia.
- To determine if targeted therapies reducing artery stiffness offer protection in coronary disease.
Main Methods:
- Review of experimental and clinical evidence.
- Analysis of the effects of existing ischemic heart disease treatments on large artery stiffness.
- Evaluation of the potential of novel agents targeting large artery stiffness.
Main Results:
- Large artery stiffening is independently associated with coronary outcomes.
- Existing cardiovascular drugs can reduce large artery stiffness through functional and structural changes.
- These drug-induced changes in artery stiffness likely contribute to their anti-ischemic effects.
Conclusions:
- Large artery stiffening plays a significant role in coronary disease pathogenesis and outcomes.
- Current treatments for ischemic heart disease possess beneficial effects on arterial stiffness.
- Further research is needed to confirm if direct targeting of large artery stiffness improves outcomes in coronary disease.
Abstract:
Large artery stiffening may be both a cause and a consequence of atherosclerosis and is independently related to coronary outcome. This relationship is likely to be causal given the unfavourable effect of large artery stiffening on coronary hemodynamics. There is clear experimental and clinical evidence that large artery stiffening promotes myocardial ischemia secondary to central pulse pressure elevation. Many agents commonly used to treat ischemic heart disease symptoms also reduce large artery stiffness, through both functional and structural mechanisms. Such effects likely contribute to the anti-ischemic actions of these drugs. However, it remains to be elucidated whether agents specifically targeted to reduce large artery stiffness provide ischemic protection in the setting of coronary disease.
Related Concept Videos
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Peripheral Artery Disease I: Introduction
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease II: Pathophysiology
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
